bisoprolol has been researched along with Angor Pectoris in 37 studies
Bisoprolol: A cardioselective beta-1 adrenergic blocker. It is effective in the management of HYPERTENSION and ANGINA PECTORIS.
| Excerpt | Relevance | Reference |
|---|---|---|
| " chronic obstructive bronchitis were treated with the beta1-selective beta-blockers atenolol (50 mg) and bisoprolol (5 mg) for 6 months in each case, following a randomized, double-blind crossover study design." | 9.06 | Long-term treatment of angina pectoris with bisoprolol or atenolol in patients with chronic obstructive bronchitis: a randomized, double-blind crossover study. ( Bethge, H; Disselhoff, G; Dorow, P; Thalhofer, S; Wagner, G, 1990) |
| "Efficacy and safety of the new beta-adrenoceptor antagonist, bisoprolol, in treatment of stable angina pectoris were studied in 36 patients using two types of single-blind design." | 9.06 | Clinical evaluation of bisoprolol in patients with stable angina pectoris: a preliminary report. ( Kanazawa, T; Kato, K; Niitani, H; Shimomura, K; Toyama, S, 1986) |
| "The effects of 5 and 10 mg bisoprolol once daily for 7 days on exercise ECG, myocardial perfusion and left ventricular function in 25 patients with stable coronary heart disease have been assessed in a double-blind, randomized, parallel group trial design." | 9.06 | Effect of bisoprolol on cardiac performance in coronary heart disease. ( Borst, U; Gerhards, W; Maisch, B; Wagner, G, 1989) |
| "A randomized, placebo-controlled, double-blind crossover investigation in 12 patients with non-asthmatic chronic obstructive lung disease and co-existing stable angina pectoris was done to compare two beta 1-selective adrenoceptor blocking agents, atenolol 100 mg and bisoprolol 20 mg." | 9.06 | Effects of single oral doses of bisoprolol and atenolol on airway function in nonasthmatic chronic obstructive lung disease and angina pectoris. ( Bethge, H; Dorow, P; Tönnesmann, U, 1986) |
| "The efficacy and safety of the new cardioselective beta-blocker bisoprolol 5 mg and 10 mg once daily in the treatment of angina pectoris was compared with atenolol 100 mg once daily." | 9.06 | A comparison of once daily bisoprolol, 5 and 10 mg, and atenolol 100 mg in the treatment of angina pectoris. ( Camm, AJ; Dymond, DS; Maltz, MB; Nathan, AW, 1987) |
| "Bisoprolol reduces systolic and diastolic blood pressures in patients with hypertension for a 24-hour dosing interval and is associated with beneficial hemodynamic effects in patients with myocardial ischemia." | 8.79 | Bisoprolol: is this just another beta-blocker for hypertension or angina? ( Johns, TE; Lopez, LM, 1995) |
| "This study assessed the real-life effectiveness of a single-pill combination (SPC) of bisoprolol/perindopril for controlling blood pressure (BP) and symptoms of angina in patients with hypertension and a history of myocardial infarction (MI)." | 8.31 | Effectiveness and Tolerability of Bisoprolol/Perindopril Single-Pill Combination in Patients with Arterial Hypertension and a History of Myocardial Infarction: The PRIDE Observational Study. ( Burtsev, Y; Kobalava, Z; Kvasnikov, B, 2023) |
| "The purpose of the study was to assess the efficacy and tolerance of the beta1-selective beta-adrenoceptor-blocking agent bisoprolol in patients with chronic stable angina pectoris." | 7.68 | Bisoprolol in the treatment of chronic stable angina pectoris. ( Plaza, L; Rodrigo, F; Terol, I, 1990) |
| " There were no significant differences regarding nature and incidence of adverse events between the groups." | 6.67 | Comparison of the safety and efficacy of bisoprolol versus atenolol in stable exercise-induced angina pectoris: a Multicenter International Randomized Study of Angina Pectoris (MIRSA). ( Buchner-Moell, D; de Muinck, ED; Lie, KI; van de Ven, LL, 1992) |
| "Bisoprolol is a new cardioselective beta-blocker with a long half-life." | 6.66 | Efficacy of once daily bisoprolol in stable angina pectoris: an objective comparison with atenolol and long term follow-up. ( Hughes, LO; Kardash, MM; Khurmi, NS; Kohli, RS; Lahiri, A; Raftery, EB, 1985) |
| "Bisoprolol is a beta 1-adrenoceptor antagonist with no partial agonist (intrinsic sympathomimetic) activity or membrane stabilising (local anaesthetic) activity." | 6.37 | Bisoprolol. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in hypertension and angina pectoris. ( Lancaster, SG; Sorkin, EM, 1988) |
| "To study effects of a cardioselective beta-adrenoblocker bisoprolol on vascular wall endothelium and external respiration function in stable angina of effort combined with chronic obstructive pulmonary disease (COPD)." | 5.35 | [Effects of beta 1-adrenoblocker bisoprolol on endothelial dysfunction in patients with stable angina pectoris in combination with chronic obstructive pulmonary disease]. ( Grigor'eva, NIu; Kontorshchikova, KN; Koroleva, EF; Kuznetsov, AN; Mazalov, KV; Sharabrin, EG, 2009) |
| "The Total Ischemic Burden Bisoprolol Study (TIBBS) was a randomized double-blind controlled study with two parallel groups; 330 patients from 30 centers in seven European countries with stable angina pectoris, a positive exercise test and more than two transient ischemic episodes during 48 h of Holter monitoring (central evaluation) were included." | 5.08 | Medical treatment to reduce total ischemic burden: total ischemic burden bisoprolol study (TIBBS), a multicenter trial comparing bisoprolol and nifedipine. The TIBBS Investigators. ( von Arnim, T, 1995) |
| " chronic obstructive bronchitis were treated with the beta1-selective beta-blockers atenolol (50 mg) and bisoprolol (5 mg) for 6 months in each case, following a randomized, double-blind crossover study design." | 5.06 | Long-term treatment of angina pectoris with bisoprolol or atenolol in patients with chronic obstructive bronchitis: a randomized, double-blind crossover study. ( Bethge, H; Disselhoff, G; Dorow, P; Thalhofer, S; Wagner, G, 1990) |
| "Efficacy and safety of the new beta-adrenoceptor antagonist, bisoprolol, in treatment of stable angina pectoris were studied in 36 patients using two types of single-blind design." | 5.06 | Clinical evaluation of bisoprolol in patients with stable angina pectoris: a preliminary report. ( Kanazawa, T; Kato, K; Niitani, H; Shimomura, K; Toyama, S, 1986) |
| "The effects of 5 and 10 mg bisoprolol once daily for 7 days on exercise ECG, myocardial perfusion and left ventricular function in 25 patients with stable coronary heart disease have been assessed in a double-blind, randomized, parallel group trial design." | 5.06 | Effect of bisoprolol on cardiac performance in coronary heart disease. ( Borst, U; Gerhards, W; Maisch, B; Wagner, G, 1989) |
| "A randomized, placebo-controlled, double-blind crossover investigation in 12 patients with non-asthmatic chronic obstructive lung disease and co-existing stable angina pectoris was done to compare two beta 1-selective adrenoceptor blocking agents, atenolol 100 mg and bisoprolol 20 mg." | 5.06 | Effects of single oral doses of bisoprolol and atenolol on airway function in nonasthmatic chronic obstructive lung disease and angina pectoris. ( Bethge, H; Dorow, P; Tönnesmann, U, 1986) |
| "The efficacy and safety of the new cardioselective beta-blocker bisoprolol 5 mg and 10 mg once daily in the treatment of angina pectoris was compared with atenolol 100 mg once daily." | 5.06 | A comparison of once daily bisoprolol, 5 and 10 mg, and atenolol 100 mg in the treatment of angina pectoris. ( Camm, AJ; Dymond, DS; Maltz, MB; Nathan, AW, 1987) |
| "Bisoprolol reduces systolic and diastolic blood pressures in patients with hypertension for a 24-hour dosing interval and is associated with beneficial hemodynamic effects in patients with myocardial ischemia." | 4.79 | Bisoprolol: is this just another beta-blocker for hypertension or angina? ( Johns, TE; Lopez, LM, 1995) |
| "This study assessed the real-life effectiveness of a single-pill combination (SPC) of bisoprolol/perindopril for controlling blood pressure (BP) and symptoms of angina in patients with hypertension and a history of myocardial infarction (MI)." | 4.31 | Effectiveness and Tolerability of Bisoprolol/Perindopril Single-Pill Combination in Patients with Arterial Hypertension and a History of Myocardial Infarction: The PRIDE Observational Study. ( Burtsev, Y; Kobalava, Z; Kvasnikov, B, 2023) |
| "The purpose of the study was to assess the efficacy and tolerance of the beta1-selective beta-adrenoceptor-blocking agent bisoprolol in patients with chronic stable angina pectoris." | 3.68 | Bisoprolol in the treatment of chronic stable angina pectoris. ( Plaza, L; Rodrigo, F; Terol, I, 1990) |
| "In 242 patients with hypertension and/or angina pectoris, a new cardioselective betablocker without ISA, bisoprolol (Concor), was tested." | 3.67 | [A new beta 1-receptor blocker in the therapy of essential hypertension and angina pectoris]. ( Burkart, F; Stamm, G; Witassek, F, 1989) |
| "Aim of this study was to assess clinical and pharmacoeconomic effects of long term use of adrenoblockers in patients with ischemic heart disease (IHD) undergoing coronary artery bypass grafting." | 2.75 | [Clinical-pharmacoeconomical aspects of ß-adrenoblockers use in patients with ischemic heart disease undergoing coronary artery bypass grafting]. ( Dronova, EP; Lopatin, IuM, 2010) |
| " There were no significant differences regarding nature and incidence of adverse events between the groups." | 2.67 | Comparison of the safety and efficacy of bisoprolol versus atenolol in stable exercise-induced angina pectoris: a Multicenter International Randomized Study of Angina Pectoris (MIRSA). ( Buchner-Moell, D; de Muinck, ED; Lie, KI; van de Ven, LL, 1992) |
| "Bisoprolol is a new cardioselective beta-blocker with a long half-life." | 2.66 | Efficacy of once daily bisoprolol in stable angina pectoris: an objective comparison with atenolol and long term follow-up. ( Hughes, LO; Kardash, MM; Khurmi, NS; Kohli, RS; Lahiri, A; Raftery, EB, 1985) |
| "Bisoprolol is a new beta1-selective beta-blocker with a clear 24-h duration of action regarding symptoms and improvement of exercise capacity in patients with stable exercise-induced angina pectoris." | 2.38 | Safety and efficacy of beta-blockers in the treatment of stable angina pectoris. ( de Muinck, ED; Lie, KI, 1990) |
| "Bisoprolol is a beta 1-adrenoceptor antagonist with no partial agonist (intrinsic sympathomimetic) activity or membrane stabilising (local anaesthetic) activity." | 2.37 | Bisoprolol. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in hypertension and angina pectoris. ( Lancaster, SG; Sorkin, EM, 1988) |
| "To study effects of a cardioselective beta-adrenoblocker bisoprolol on vascular wall endothelium and external respiration function in stable angina of effort combined with chronic obstructive pulmonary disease (COPD)." | 1.35 | [Effects of beta 1-adrenoblocker bisoprolol on endothelial dysfunction in patients with stable angina pectoris in combination with chronic obstructive pulmonary disease]. ( Grigor'eva, NIu; Kontorshchikova, KN; Koroleva, EF; Kuznetsov, AN; Mazalov, KV; Sharabrin, EG, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 13 (35.14) | 18.7374 |
| 1990's | 12 (32.43) | 18.2507 |
| 2000's | 5 (13.51) | 29.6817 |
| 2010's | 6 (16.22) | 24.3611 |
| 2020's | 1 (2.70) | 2.80 |
| Authors | Studies |
|---|---|
| Kobalava, Z | 1 |
| Kvasnikov, B | 1 |
| Burtsev, Y | 1 |
| Sabidó, M | 1 |
| Thilo, H | 1 |
| Guido, G | 1 |
| Fi, Z | 1 |
| Szentes, V | 1 |
| Olivotto, I | 1 |
| Cecchi, F | 1 |
| Bini, R | 1 |
| Favilli, S | 1 |
| Murzi, B | 1 |
| El-Hamamsy, I | 1 |
| Yacoub, MH | 1 |
| Grigor'eva, NIu | 1 |
| Sharabrin, EG | 1 |
| Kuznetsov, AN | 1 |
| Mazalov, KV | 1 |
| Kontorshchikova, KN | 1 |
| Koroleva, EF | 1 |
| Fazio, G | 1 |
| Sarulo, F | 1 |
| Licata, P | 1 |
| D'Angelo, L | 1 |
| Passantino, S | 1 |
| Visconti, C | 1 |
| Zarcone, P | 1 |
| Spanò, C | 1 |
| Novo, G | 1 |
| Novo, S | 1 |
| Inaba, S | 1 |
| Okayama, H | 1 |
| Higashi, H | 1 |
| Nishimura, K | 1 |
| Inoue, K | 1 |
| Ogimoto, A | 1 |
| Higaki, J | 1 |
| Lopatin, IuM | 1 |
| Dronova, EP | 1 |
| Ageev, FT | 1 |
| Makarova, GV | 1 |
| Patrusheva, IF | 1 |
| Orlova, IaA | 1 |
| Cabrera-Bueno, F | 1 |
| García-Pinilla, JM | 1 |
| Gómez-Doblas, JJ | 1 |
| Montiel-Trujillo, A | 1 |
| Rodríguez-Bailón, I | 1 |
| de Teresa-Galván, E | 1 |
| Dupliakov, DV | 1 |
| Glukhova, VL | 1 |
| Vozhdaeva, ZI | 1 |
| Golovina, GA | 1 |
| Smedema, JP | 1 |
| Berlion, AE | 1 |
| Morkel, H | 1 |
| Prager, G | 2 |
| Wagner, G | 4 |
| Johns, TE | 1 |
| Lopez, LM | 1 |
| van de Ven, LL | 2 |
| Vermeulen, A | 1 |
| Tans, JG | 1 |
| Tans, AC | 1 |
| Liem, KL | 1 |
| Lageweg, NC | 1 |
| Lie, KI | 4 |
| von Arnim, T | 2 |
| Rayo Llerena, I | 1 |
| Marín Huerta, E | 1 |
| Bixby, MB | 1 |
| Weber, F | 1 |
| Schneider, H | 1 |
| Urbaszek, W | 1 |
| de Muinck, ED | 2 |
| Schnellbacher, K | 1 |
| Bestehorn, HP | 1 |
| Roskamm, H | 1 |
| Terol, I | 1 |
| Plaza, L | 1 |
| Rodrigo, F | 1 |
| Dorow, P | 2 |
| Thalhofer, S | 1 |
| Bethge, H | 2 |
| Disselhoff, G | 1 |
| Buchner-Moell, D | 1 |
| Graffius, D | 1 |
| Kato, K | 1 |
| Niitani, H | 1 |
| Kanazawa, T | 1 |
| Shimomura, K | 1 |
| Toyama, S | 1 |
| Kohli, RS | 2 |
| Lahiri, A | 2 |
| Raftery, EB | 2 |
| Prager, W | 1 |
| Hönig, B | 1 |
| Maisch, B | 1 |
| Borst, U | 1 |
| Gerhards, W | 1 |
| Burkart, F | 1 |
| Stamm, G | 1 |
| Witassek, F | 1 |
| Khurmi, NS | 1 |
| Kardash, MM | 1 |
| Hughes, LO | 1 |
| Tönnesmann, U | 1 |
| de Muinck, E | 1 |
| vd Ven, LL | 1 |
| Lancaster, SG | 1 |
| Sorkin, EM | 1 |
| Maltz, MB | 1 |
| Dymond, DS | 1 |
| Nathan, AW | 1 |
| Camm, AJ | 1 |
| De Divitiis, O | 1 |
| Liguori, V | 1 |
| Di Somma, S | 1 |
| Brignoli, M | 1 |
| Ferraro, S | 1 |
| Petitto, M | 1 |
| Fazio, S | 1 |
| Marsullo, G | 1 |
| Salvatore, M | 1 |
| Gradnik, R | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Heart Rate Lowering Efficacy and Respiratory Safety of Ivabradine in Patients With Obstructive Airway Disease[NCT01365286] | Phase 4 | 40 participants (Actual) | Interventional | 2009-05-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
5 reviews available for bisoprolol and Angor Pectoris
| Article | Year |
|---|---|
[The benefits of carvedilol therapy in the treatment of patients with high cardiovascular risk].
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Antihypertensive Agents; Bisoprolol; Carbazoles; Cardi | 2016 |
Bisoprolol: is this just another beta-blocker for hypertension or angina?
Topics: Angina Pectoris; Bisoprolol; Clinical Trials as Topic; Drug Interactions; Electrophysiology; Hemodyn | 1995 |
[Silent myocardial ischemia. Arguments against treatment].
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Angina, Unstable; Atenolol; Bisoprolol; Calcium Channe | 1996 |
Safety and efficacy of beta-blockers in the treatment of stable angina pectoris.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Animals; Bisoprolol; Blood Pressure; Heart Rate; Human | 1990 |
Bisoprolol. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in hypertension and angina pectoris.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Animals; Bisoprolol; Humans; Hypertension; Propanolami | 1988 |
20 trials available for bisoprolol and Angor Pectoris
| Article | Year |
|---|---|
[Clinical-pharmacoeconomical aspects of ß-adrenoblockers use in patients with ischemic heart disease undergoing coronary artery bypass grafting].
Topics: Adrenergic beta-1 Receptor Antagonists; Angina Pectoris; Atenolol; Bisoprolol; Comparative Effective | 2010 |
[The efficacy and safety of the combination of β-blocker bisoprolol and if inhibitor I(f) ivabradine in patients with stable angina and chronic obstructive pulmonary disease].
Topics: Administration, Inhalation; Adrenergic beta-1 Receptor Antagonists; Aged; Angina Pectoris; Benzazepi | 2010 |
Beta-blocker therapy for dynamic left ventricular outflow tract obstruction induced by exercise.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Bisoprolol; Cardiomyopathy, Hypertrophic; Echocardiogr | 2007 |
[Cardioselective beta-adrenoblockers in patients with stable angina pectoris. Comparison of efficacy and safety].
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Benzopyrans; Betaxolol; Bisoprolol; Blood Flow Velocit | 2006 |
[Effect of bisoprolol in coronary heart disease. Effect on cardiovascular parameters and ischemic ST depression: studies on the duration of the effect].
Topics: Adrenergic beta-Antagonists; Aged; Angina Pectoris; Bisoprolol; Clinical Trials as Topic; Coronary D | 1984 |
Which drug to choose for stable angina pectoris: a comparative study between bisoprolol and nitrates.
Topics: Adult; Aged; Angina Pectoris; Bisoprolol; Blood Pressure; Cross-Over Studies; Double-Blind Method; D | 1995 |
Medical treatment to reduce total ischemic burden: total ischemic burden bisoprolol study (TIBBS), a multicenter trial comparing bisoprolol and nifedipine. The TIBBS Investigators.
Topics: Adult; Aged; Angina Pectoris; Bisoprolol; Double-Blind Method; Electrocardiography, Ambulatory; Euro | 1995 |
Heart rate variability and ischaemia in patients with coronary heart disease and stable angina pectoris; influence of drug therapy and prognostic value. TIBBS Investigators Group. Total Ischemic Burden Bisoprolol Study.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Angina Pectoris; Bisoprolol; Calcium Channel Blockers; Cir | 1999 |
Hemodynamics and exercise tolerance after bisoprolol, nifedipine, and their combination in patients with angina pectoris.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Angina Pectoris; Bisoprolol; Calcium Channel Blockers; Dou | 1990 |
Long-term treatment of angina pectoris with bisoprolol or atenolol in patients with chronic obstructive bronchitis: a randomized, double-blind crossover study.
Topics: Adrenergic beta-1 Receptor Antagonists; Adrenergic beta-Antagonists; Adult; Aged; Airway Resistance; | 1990 |
Comparison of the safety and efficacy of bisoprolol versus atenolol in stable exercise-induced angina pectoris: a Multicenter International Randomized Study of Angina Pectoris (MIRSA).
Topics: Adult; Aged; Aged, 80 and over; Angina Pectoris; Atenolol; Bisoprolol; Double-Blind Method; Electroc | 1992 |
[New specialty drugs registered in Austria. Concor].
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Austria; Bisoprolol; Clinical Trials as Topic; Coronar | 1990 |
Clinical evaluation of bisoprolol in patients with stable angina pectoris: a preliminary report.
Topics: Adrenergic beta-Antagonists; Aged; Angina Pectoris; Bisoprolol; Blood Pressure; Clinical Trials as T | 1986 |
Management of chronic stable angina with once-daily bisoprolol or atenolol and long-term efficacy of bisoprolol.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Angina Pectoris; Atenolol; Bisoprolol; Chronic Disease; Do | 1986 |
Effect of bisoprolol on cardiac performance in coronary heart disease.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Angina Pectoris; Bisoprolol; Blood Pressure; Coronary Circ | 1989 |
Efficacy of once daily bisoprolol in stable angina pectoris: an objective comparison with atenolol and long term follow-up.
Topics: Administration, Oral; Adrenergic beta-Antagonists; Adult; Aged; Angina Pectoris; Atenolol; Bisoprolo | 1985 |
Effects of single oral doses of bisoprolol and atenolol on airway function in nonasthmatic chronic obstructive lung disease and angina pectoris.
Topics: Adrenergic beta-Antagonists; Adult; Airway Resistance; Angina Pectoris; Atenolol; Bisoprolol; Double | 1986 |
Comparison of the effects of two doses of bisoprolol on exercise tolerance in exercise-induced stable angina pectoris.
Topics: Administration, Oral; Adrenergic beta-Antagonists; Adult; Aged; Angina Pectoris; Bisoprolol; Blood P | 1987 |
A comparison of once daily bisoprolol, 5 and 10 mg, and atenolol 100 mg in the treatment of angina pectoris.
Topics: Aged; Angina Pectoris; Atenolol; Bisoprolol; Chronic Disease; Clinical Trials as Topic; Drug Adminis | 1987 |
Bisoprolol in the treatment of angina pectoris: a double blind comparison with verapamil.
Topics: Adult; Angina Pectoris; Bisoprolol; Double-Blind Method; Drug Administration Schedule; Electrocardio | 1987 |
12 other studies available for bisoprolol and Angor Pectoris
| Article | Year |
|---|---|
Effectiveness and Tolerability of Bisoprolol/Perindopril Single-Pill Combination in Patients with Arterial Hypertension and a History of Myocardial Infarction: The PRIDE Observational Study.
Topics: Aged; Angina Pectoris; Antihypertensive Agents; Bisoprolol; Blood Pressure; Drug Combinations; Femal | 2023 |
Long-term effectiveness of bisoprolol in patients with angina: A real-world evidence study.
Topics: Adolescent; Adrenergic beta-1 Receptor Antagonists; Adult; Aged; Angina Pectoris; Bisoprolol; Female | 2019 |
Tunneled left anterior descending artery in a child with hypertrophic cardiomyopathy.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Bisoprolol; Cardiac Surgical Procedures; Cardiomyopath | 2009 |
[Effects of beta 1-adrenoblocker bisoprolol on endothelial dysfunction in patients with stable angina pectoris in combination with chronic obstructive pulmonary disease].
Topics: Adrenergic beta-Antagonists; Aged; Angina Pectoris; Bisoprolol; Endothelium, Vascular; Female; Human | 2009 |
Ivabradine versus bisoprolol.
Topics: Adrenergic beta-Antagonists; Aged; Angina Pectoris; Arrhythmias, Cardiac; Benzazepines; Bisoprolol; | 2010 |
Usefulness of transthoracic Doppler echocardiography for noninvasive assessment of coronary blood flow in a patient with symptomatic myocardial bridging.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Bisoprolol; Blood Flow Velocity; Coronary Angiography; | 2011 |
Myocardial infarcts in a patient with a single right sided coronary ostium and interarterial course of the circumflex artery: the role of multi-modality imaging.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Anticholesteremic Agents; Antihypertensive Agents; Asp | 2009 |
Successful medical management of a patient with an anomalous right coronary artery who declined surgery.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Bisoprolol; Cardiac Catheterization; Coronary Artery B | 1998 |
Bisoprolol in the treatment of chronic stable angina pectoris.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Angina Pectoris; Bisoprolol; Chi-Square Distribution; Chro | 1990 |
Effect of beta-adrenergic blockade on the circadian rhythm of myocardial ischemia in ambulatory patients with stable angina.
Topics: Adrenergic beta-Antagonists; Aged; Ambulatory Care; Angina Pectoris; Bisoprolol; Circadian Rhythm; C | 1989 |
[A new beta 1-receptor blocker in the therapy of essential hypertension and angina pectoris].
Topics: Adrenergic beta-Antagonists; Aged; Angina Pectoris; Bisoprolol; Female; Hemodynamics; Humans; Hypert | 1989 |
Bisoprolol--another cardioselective beta blocker.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Bisoprolol; Humans; Hypertension; Propanolamines | 1989 |